APYX - Apyx Medical Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Revenue 16,686 10,234 8,819 29,520
Cost of Revenue 5,893 3,276 3,703 16,963
Gross Profit 10,793 6,958 5,116 12,557
Operating Expenses
Research Development 2,469 1,941 1,033 2,160
Selling General and Administrative 21,183 17,378 15,475 17,383
Non Recurring - - - -
Others - - - -
Total Operating Expenses 29,545 22,595 20,211 36,506
Operating Income or Loss -12,859 -12,361 -11,392 -6,986
Income from Continuing Operations
Total Other Income/Expenses Net -412 -1,477 -94 1,641
Earnings Before Interest and Taxes -12,859 -12,361 -11,392 -6,986
Interest Expense -104 -136 -158 -158
Income Before Tax -13,271 -13,838 -11,486 -5,345
Income Tax Expense -3,777 -156 64 25
Minority Interest - - - -
Net Income From Continuing Ops -9,494 -13,682 -11,550 -5,370
Non-recurring Events
Discontinued Operations 73,503 8,620 7,600 7,600
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income 64,009 -5,062 -3,950 -5,370
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares 64,009 -5,062 -3,950 8,364